1. Home
  2. PAHC vs ARDX Comparison

PAHC vs ARDX Comparison

Compare PAHC & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAHC
  • ARDX
  • Stock Information
  • Founded
  • PAHC 1946
  • ARDX 2007
  • Country
  • PAHC United States
  • ARDX United States
  • Employees
  • PAHC N/A
  • ARDX N/A
  • Industry
  • PAHC Biotechnology: Pharmaceutical Preparations
  • ARDX Biotechnology: Pharmaceutical Preparations
  • Sector
  • PAHC Health Care
  • ARDX Health Care
  • Exchange
  • PAHC Nasdaq
  • ARDX Nasdaq
  • Market Cap
  • PAHC 968.3M
  • ARDX 885.2M
  • IPO Year
  • PAHC 2014
  • ARDX 2014
  • Fundamental
  • Price
  • PAHC $23.88
  • ARDX $3.56
  • Analyst Decision
  • PAHC Sell
  • ARDX Strong Buy
  • Analyst Count
  • PAHC 4
  • ARDX 9
  • Target Price
  • PAHC $20.00
  • ARDX $10.17
  • AVG Volume (30 Days)
  • PAHC 224.9K
  • ARDX 4.5M
  • Earning Date
  • PAHC 05-07-2025
  • ARDX 07-31-2025
  • Dividend Yield
  • PAHC 2.01%
  • ARDX N/A
  • EPS Growth
  • PAHC 140.17
  • ARDX N/A
  • EPS
  • PAHC 0.78
  • ARDX N/A
  • Revenue
  • PAHC $1,190,682,000.00
  • ARDX $361,706,000.00
  • Revenue This Year
  • PAHC $28.33
  • ARDX $12.01
  • Revenue Next Year
  • PAHC $13.78
  • ARDX $34.66
  • P/E Ratio
  • PAHC $30.60
  • ARDX N/A
  • Revenue Growth
  • PAHC 19.12
  • ARDX 127.33
  • 52 Week Low
  • PAHC $16.16
  • ARDX $3.21
  • 52 Week High
  • PAHC $26.55
  • ARDX $8.06
  • Technical
  • Relative Strength Index (RSI)
  • PAHC 53.14
  • ARDX 40.62
  • Support Level
  • PAHC $23.83
  • ARDX $3.63
  • Resistance Level
  • PAHC $25.15
  • ARDX $3.72
  • Average True Range (ATR)
  • PAHC 0.69
  • ARDX 0.19
  • MACD
  • PAHC -0.19
  • ARDX 0.01
  • Stochastic Oscillator
  • PAHC 44.85
  • ARDX 4.65

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: